| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -404.54K | $ -392.74K | $ -745.59K | $ -769.69K | $ -604.40K |
| Operating Income | $ -11.72M | $ -3.77M | $ -4.74M | $ -6.27M | $ -7.62M |
| EBITDA | $ -11.32M | $ -3.19M | $ -3.62M | $ -5.29M | $ -6.99M |
| Net Income | $ -11.70M | $ -3.58M | $ -4.30M | $ -5.87M | $ -7.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 14.19M | $ 4.90M | $ 7.96M | $ 11.56M | $ 16.42M |
| Total Assets | $ 14.73M | $ 5.76M | $ 8.44M | $ 12.62M | $ 18.02M |
| Total Debt | $ 295.81K | $ 544.41K | $ 85.74K | $ 463.67K | $ 771.25K |
| Net Debt | $ -13.90M | $ -1.87M | $ -2.88M | $ -1.10M | $ -5.65M |
| Total Liabilities | $ 1.38M | $ 895.31K | $ 219.51K | $ 632.32K | $ 938.03K |
| Stockholders' Equity | $ 13.35M | $ 4.86M | $ 8.22M | $ 12.03M | $ 17.07M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.70M | $ -3.27M | $ -4.01M | $ -4.99M | $ -6.05M |
| Operating Cash Flow | $ -7.70M | $ -3.11M | $ -4.00M | $ -4.96M | $ -5.27M |
| Investing Cash Flow | $ 2.50M | $ 2.69M | $ 5.24M | $ 58.98K | $ -10.78M |
| Financing Cash Flow | $ 16.95M | $ 0.00 | $ 102.28K | $ 134.91K | $ 22.41M |
Regencell Bioscience Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.